| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30005680 | HIV | ENSG00000166197.17 | protein_coding | NOLC1 | No | No | 9221 | Q14978 Q96J17 |
| TVIS30028469 | HIV | ENSG00000166197.17 | protein_coding | NOLC1 | No | No | 9221 | Q14978 Q96J17 |
| TVIS44046571 | HTLV-1 | ENSG00000166197.17 | protein_coding | NOLC1 | No | No | 9221 | Q14978 Q96J17 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | NOLC1 |
|---|---|
| DrugBank ID | DB00997 |
| Drug Name | Doxorubicin |
| Target ID | BE0005819 |
| UniProt ID | Q14978 |
| Regulation Type | |
| PubMed IDs | 17129415 |
| Citations | Kim YK, Lee WK, Jin Y, Lee KJ, Jeon H, Yu YG: Doxorubicin binds to un-phosphorylated form of hNopp140 and reduces protein kinase CK2-dependent phosphorylation of hNopp140. J Biochem Mol Biol. 2006 Nov 30;39(6):774-81. |
| Groups | Approved; Investigational |
| Direct Classification | Anthracyclines |
| SMILES | COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O |
| Pathways | Doxorubicin Metabolism Pathway |
| PharmGKB | PA449412 |
| ChEMBL | CHEMBL53463 |
